The effect of pentaerythritol tetranitrate pretreatment on experimental coronary occlusion.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000503:physiopathology; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004617:Embolism / Q000209:etiology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D010100:Oxygen / Q000097:blood; D010417:Pentaerythritol Tetranitrate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D010417:Pentaerythritol Tetranitrate; D002245:Carbon Dioxide; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D010100:Oxygen